technetium tc 99m pentetate has been researched along with Experimental Mammary Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, JL; Hall, DJ; Hayashi, T; Hosseini, A; Qin, Z; Stupak, DG; Tokin, CA; Vera, DR; Wallace, AM | 1 |
Parviainen, S; Paul, R | 1 |
2 other study(ies) available for technetium tc 99m pentetate and Experimental Mammary Neoplasms
Article | Year |
---|---|
Fluorescent-tilmanocept for tumor margin analysis in the mouse model.
Topics: Animals; Benzothiazoles; Carbocyanines; CD11c Antigen; Cell Line; Cell Line, Tumor; Dendritic Cells; Dextrans; Female; Mammary Neoplasms, Experimental; Mannans; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Microscopy, Fluorescence; Technetium Tc 99m Pentetate; Ultraviolet Rays | 2014 |
Dynamic (18F)-2-fluoro-2-deoxy-D-glucose (FDG) scintigraphy of normal and tumor-bearing rats.
Topics: Animals; Brain; Deoxy Sugars; Deoxyglucose; Female; Fluorodeoxyglucose F18; Half-Life; Heart; Kidney; Kidney Neoplasms; Liver; Mammary Neoplasms, Experimental; Pentetic Acid; Radioisotope Renography; Rats; Rats, Inbred Strains; Sarcoma, Avian; Technetium; Technetium Tc 99m Pentetate | 1986 |